New data from TAILORx, the federally funded, phase three clinical trial, will be presented as late-breaking information at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
From https://jamesjohnson10.blogspot.com/2019/09/late-breaking-tailorx-data-to-be.html
from
https://jamesjohnson10.wordpress.com/2019/09/26/late-breaking-tailorx-data-to-be-presented-at-esmo-congress-2019/
No comments:
Post a Comment